rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anne Sempowski Ward

Director

Company insider

Files Form 4 as: Director, Vanda Pharmaceuticals; Director, SPS Commerce; Director, Spectrum Brands Holdings.

In numbers

Trades disclosed
29
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
28 Oct 2019
Last trade
4 Jun 2026
Last filed
8 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VNDA Vanda PharmaceuticalsDirector · Pharmaceuticals · last 4 Jun 20260 buys · 0 sells
SPSC SPS CommerceDirector · Software · last 28 May 20260 buys · 0 sells
SPB Spectrum Brands HoldingsDirector · Electronic Components & EMS · last 22 Dec 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 8 Jun 2026VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—41,600 at $0.00filing
4 Jun 2026filed 8 Jun 2026VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—41,600 at $0.00filing
28 May 2026filed 1 Jun 2026SPSC SPS CommerceSoftwareSEC FORM 4 Code A—3,736 at $0.00filing
28 May 2026filed 1 Jun 2026SPSC SPS CommerceSoftwareSEC FORM 4 Code A—3,736 at $0.00filing
5 Jun 2025filed 9 Jun 2025VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—59,225 at $0.00filing
13 May 2025filed 15 May 2025SPSC SPS CommerceSoftwareSEC FORM 4 Code A—1,310 at $0.00filing
17 May 2024filed 21 May 2024VNDA Vanda Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—37,578 at $0.00filing
17 May 2024filed 21 May 2024VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—20,529 at $0.00filing
16 May 2024filed 20 May 2024SPSC SPS Commerceoption or derivative · SoftwareSEC FORM 4 Code A—1,136 at $0.00filing
16 May 2024filed 20 May 2024SPSC SPS CommerceSoftwareSEC FORM 4 Code A—465 at $0.00filing
8 Jun 2023filed 12 Jun 2023VNDA Vanda Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—33,960 at $0.00filing
8 Jun 2023filed 12 Jun 2023VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—17,307 at $0.00filing
12 May 2023filed 16 May 2023SPSC SPS Commerceoption or derivative · SoftwareSEC FORM 4 Code A—1,466 at $0.00filing
12 May 2023filed 16 May 2023SPSC SPS CommerceSoftwareSEC FORM 4 Code A—585 at $0.00filing
16 Jun 2022filed 21 Jun 2022VNDA Vanda Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—24,707 at $0.00filing
16 Jun 2022filed 21 Jun 2022VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—12,006 at $0.00filing
17 May 2022filed 19 May 2022SPSC SPS Commerceoption or derivative · SoftwareSEC FORM 4 Code A—2,252 at $0.00filing
17 May 2022filed 19 May 2022SPSC SPS CommerceSoftwareSEC FORM 4 Code A—838 at $0.00filing
10 Jun 2021filed 14 Jun 2021VNDA Vanda PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—5,000 at $0.00filing
10 Jun 2021filed 14 Jun 2021VNDA Vanda Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—10,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Phaedra ChrousosDirector · Director at Vanda Pharmaceuticals, filing Form 4 there in the last year
Stephen Ray MitchellDirector · Director at Vanda Pharmaceuticals, filing Form 4 there in the last year
Richard W. DuganDirector · Director at Vanda Pharmaceuticals, filing Form 4 there in the last year
Daniel Patrick McGuireSVP, GC and Secretary · SVP, GC and Secretary at Vanda Pharmaceuticals, filing Form 4 there in the last year
Charles Cliff DuncanDirector · Director at Vanda Pharmaceuticals, filing Form 4 there in the last year